FDA Proposes to Drop Second Appeals for Medical Product Classifications

Drug Industry Daily
A A
A process for second appeals of FDA designations for medical product classifications would be eliminated under a new FDA proposed rule.

To View This Article:

Login

Subscribe To Drug Industry Daily